| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |